Record Date Set for Extraordinary General Meeting, No Shareholder Value Impact

Icure Pharmaceutical has set the record date as July 14, 2026 to determine shareholders entitled to vote at the extraordinary general meeting.
This record date setting follows the electronic registration system without a share register closure period and involves no capital changes or share issuance.
[AI Summary]This disclosure of record date setting is a procedural step for convening a shareholders meeting with zero financial impact such as dilution or capital raising. Shareholder value remains unchanged and the event is neutral.